PulmCCM
SEPTEMBER 28, 2023
with Covid-19 randomized to 800 μg of inhaled budesonide twice daily had significantly fewer urgent care visits, and faster resolution of symptoms. In the STOIC trial (a phase 2, open-label, randomized trial), 146 outpatients in the U.K.
The Skeptics' Guide to EM
JANUARY 22, 2022
Early in the pandemic, there was some observational data that concluded that inhaled steroids were associated with an increased mortality from COVID-19 in patients with asthma and COPD ( Schultze Lancet Resp Med 2020 ). However, the most likely explanation was not causal. It did report positive results.
Expert insights. Personalized for you.
95 
Let's personalize your content